Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 300 de 1001 resultados encontrados
Opções avançadas
Data de publicação: 16/02/2022 - 16:01
A technological innovation may contribute to the quest for the leprosy elimination, one of the humanity oldest diseases. An international team of scientists, led by the Oswaldo Cruz Institute (IOC/Fiocruz), in partnership with Microsoft AI for Health and the Novartis Foundation, has developed a diagnostic assistant, based on artificial intelligence, which can help identify suspected leprosy lesions. The technology has been called AI4Leprosy...
Data de publicação: 15/02/2022 - 14:38
Looking at the map, the distance between the countries is big. Within the American continent, Mexico is the Spanish-speaking country that is farthest away from Brazil. But the two nations are closer to each other than it may seem. Fiocruz and Mexican institutions have joint projects, a cooperation that can expand even further, judging by the interest demonstrated by consul Héctor Humberto Valezzi Zafra. Together with the deputy consul in...
Data de publicação: 15/02/2022 - 12:19
COVID-19 diagnostics, therapeutics, and vaccines are powerful reminders: health technologies can help to shape the way in which societies control disease. Challenges in ensuring global, equitable access to these fruits of biomedical research and development (R&D) during the COVID-19 pandemic have highlighted the urgency of reorienting the system towards the public interest. The first step is a clearer articulation of what R&D in the...
Data de publicação: 15/02/2022 - 10:42
In a geopolitical context marked by disputes and inequalities, there are many economic, social, and environmental challenges in the path of those aiming to reduce these inequalities and achieve better global health outcomes. Based on this point of view, issues such as multilateralism and a possible new world order were discussed last Thursday (February 10) during the first Advanced Seminar in Global Health and Health Diplomacy this year....
Data de publicação: 09/02/2022 - 17:07
A study analyzed the geographic distribution and the incidence of co-infection with a human T-lymphotropic virus (HTLV) and a human immunodeficiency virus (HIV) in Bahia, which is an endemic state for both retroviruses. The research was carried out using all samples submitted to serological tests at the Central Public Health Laboratory of Bahia (Lacen-BA), from 2004 to 2013. The total was about 130,000 samples from 358 of the 417 municipalities...
Data de publicação: 08/02/2022 - 16:21
As reported by the State Health Secretariats of Rio de Janeiro and Santa Catarina, Fiocruz has identified three cases of the BA.2 lineage of the Omicron variant, using genetic sequencing. Two of the cases occurred in Rio de Janeiro and the other in the southern state of Santa Catarina. The findings were confirmed by the Laboratory of Measles and Respiratory Viruses of the Oswaldo Cruz Institute (IOC/Fiocruz), a national reference center for...
Data de publicação: 08/02/2022 - 16:00
The Fiocruz Genomic Network has released new data on the status of lineages and variants of the Sars-CoV-2 in Brazil, based on the genomic surveillance produced by the Network and by other initiatives. According to the publication, while in December 39.4% of sequenced genomes belonged to the Omicron variant, in January 2022 this rate rose to 95.9%. The variant has now been found in all of the country’s regions. The Network Report shows...
Data de publicação: 03/02/2022 - 15:13
Celebrated last Sunday (January 30), the World Neglected Tropical Diseases Day draws attention to infections that affect more than one billion people worldwide, and yet receive little in terms of attention and investment. These diseases, such as Chagas disease, dengue fever, leishmaniasis, hanseniasis, schistosomiasis and worm-related illnesses, affect mostly poor people, resulting in death or in great health problems, worsening people’s...
Data de publicação: 31/01/2022 - 16:09
When a new advisory group of the World Health Organization (WHO) for neglected diseases holds its first meeting this Friday, January 1st, there will be a Brazilian in the room. Thiago Moreno L. Souza, a researcher of the Center for Technological Development in Health (CDTS/Fiocruz), is one of the 14 participants from all over the world selected for the Strategic and Technical Advisory Group which will be working with the Working Group for...
Data de publicação: 31/01/2022 - 14:22
Researchers of the Albert Einstein College of Medicine, in the United States, in a partnership with the Oswaldo Cruz Institute (IOC/Fiocruz) and with the University of São Paulo (USP) and other institutions, have given an important step towards the finding of a treatment for yellow fever. Considered a worldwide trend, synthetic monoclonal antibodies have been the subject of studies all over the planet. These antibodies are laboratory...
Data de publicação: 19/01/2022 - 17:49
We all had some degree of hope that the end of 2021 and the beginning of 2022 would bring us the much-awaited retraction of the pandemic. However, the emergence of the new Omicron variant dragged us away from the end of the tunnel we were longing for. Many countries, including some with powerful health systems, excellent living conditions, and high levels of vaccination, are hitting record numbers of contagions every day. So far, the...
Data de publicação: 19/01/2022 - 17:26
Science, technology and innovation to create resiliency, recover the planet from the impacts of COVID-19 and prepare it to face future health crises, including the ones resulting from environmental problems. This was the focus of the Global Sustainable Technology and Inovation Conference (G-Stic), an international reference in the debate that relates science, technology and innovation to the 2030 Agenda, which took place in Dubai from January...
Data de publicação: 19/01/2022 - 13:53
At a moment in which the world is watching a new peak of COVID-19 cases, preliminary analysis of a study on safetey and immunogenicity indicate that the use of the AstraZeneca vaccine as a booster shot increases the immune response against the variants of concern Beta, Delta, Alpha, and Gamma. An analysis made separately with samples of the research also shows an increased response of antibodies against the Omicron variant, which is behind the...
Data de publicação: 10/01/2022 - 14:43
This Friday (January 7), Fiocruz received assent from the National Agency of Sanitary Surveillance (Anvisa) for the alteration in the register of the COVID-19 vaccine (recombinant), which requested the addition of the Foundation as a producer of the Active Pharmaceutical Ingredient (API). After the transference of the AstraZeneca technology and with the approval of Anvisa, the Foundation is now the first institution in the country that is...
Data de publicação: 04/01/2022 - 15:30
A study published on medRXiv, this Wednesday (December 29th), shows that the four vaccines applied in Brazil provide a high degree of additional protection against symptomatic infections and severe cases of COVID-19 in people who had already contracted Sars-CoV-2 previously. The study, led by Julio Croda and Manoel Barral-Neto, Fiocruz researchers, also reinforces the importance of a full vaccination scheme, even for those people. Vaccine...
Data de publicação: 03/01/2022 - 15:54
Boletim Internacional
Data de publicação: 03/01/2022 - 13:05
A third AstraZeneca vaccine dose significantly increases neutralizing antibodies levels against the Ômicron variant (B.1.1.529), a new study indicates. The research was conducted independently by researchers from different institutions, including Fiocruz and Oxford University. And these results were published in preprint form on the bioRxiv platform (Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses) on...
Data de publicação: 03/01/2022 - 12:40
For three consecutive mornings in Brazil, or three nights on the other side of the world, in China, the CAS-Fiocruz webinar on Infectous Diseases brought together researchers from the Foundation and the Chinese Academy of Sciences to exchange information on topics such as COVID-19, vaccines, zika, dengue, and other diseases common to both sides of the globe. The webinar took place on December 14th, 15th, and 16th. The event opening, on...
Data de publicação: 23/12/2021 - 10:44
As with other COVID-19 immunizers, a booster dose of AstraZeneca vaccine is also required after the complete vaccination schedule. This is indicated by a new study involving Brazil and Scotland, and published in the scientific journal The Lancet on Monday (12/20). The research, of which Fiocruz is part, shows the decrease in vaccine protection over time and in face of the new variants’ emergence. The assessment, carried out at a time of...
Data de publicação: 23/12/2021 - 09:52
The ties between Fiocruz and the United States Consulate in Rio de Janeiro should become closer next year. On 12/16, the consul Jacqueline Ward and the president of Fiocruz, Nísia Trindade Lima, met at the Official Residence. On the agenda, scientific cooperation between Brazilian and American institutions, the XVI National Malaria Research Meeting and a parallel symposium organized by the Foundation and the National Institute of Allergy...
Data de publicação: 17/12/2021 - 12:41
Continuing an institutional movement to promote science through the dissemination of actions, research, events and courses in other languages, Fiocruz has just incorporated two new courses to the Global Health Training Centre. This time they were "What is Open Science?" and "Open Access", which were translated from Portuguese into English and Spanish. They integrate the series on Open Science developed by the Fiocruz Virtual...
Data de publicação: 17/12/2021 - 12:14
When the World Health Organization (WHO) decided to classify the Omicron strain of the new coronavirus as a variant of concern, it took into account the recommendations of a group of specialists. The so-called Technical Advisory Group on Sars-CoV-2 Evolution (TAG-VE) is a select group of scientists that includes a Brazilian virologist in its line-up: Brazilian researcher Marilda Siqueira, chief of the Laboratory of Measles and Respiratory...
Data de publicação: 16/12/2021 - 09:50
A project resulting from a partnership between the Ministry of Health, Fiocruz, Lacen-PR, and the Federal University of São Paulo (Unifesp) was one of those selected by the U.S. Centers for Disease Control and Prevention (CDC) for funding, as part of the creation of two global networks aimed at fighting antimicrobial resistance. With Ana Paula Assef, head of the Hospital Infection Research Laboratory (LAPIH) at the Oswaldo Cruz Institute...
Data de publicação: 16/12/2021 - 09:23
The first edition of the bulletin on the COVID-19 vaccines' effectiveness in the Brazilian population, from Fiocruz's Vigivac project, was published on Thursday (12/9). The report, which presents analyses of the four vaccines administered in Brazil from January to October 2021, points out that all of them confer a great reduction in the risk of infection, hospitalizations, and death from COVID-19. Considering serious outcomes (...
Data de publicação: 14/12/2021 - 17:24
In a pioneering initiative, the Foundation inaugurates this Monday (13/12), COVID-19 Biobank (BC19-Fiocruz). Located in Rio de Janeiro, at Expansão campus, BC19-Fiocruz will enable the design and conduct of research, technological development and clinical trials related to COVID-19, regardless of the geographic location of human biological material and viruses. With the capacity to store up to one and a half million samples of human and...


Back to the topBack